Northwestern Medicine scientists have discovered an unexpected connection between a protein implicated in neuropsychiatric disorders and the endocannabinoid pathway.
A mental health smartphone app developed by a team of Northwestern Medicine investigators helped improve depressive symptoms in patients with diabetes and hypertension, according to a recent clinical trial published in JAMA.
Alterations in the balance of two chloride transporters may be responsible for cognitive deficits in schizophrenia, according to a Northwestern Medicine study.
Feinberg investigators continue to investigate new treatments for COVID-19 and share insights on combating misinformation and mitigating the disease’s spread.
Homer1, a protein that’s important for neural plasticity and learning, is part of a large network of proteins in the brain that help ensure new connections are wired correctly, according to a new study.
Northwestern Medicine experts discuss the phenomenon of “caution fatigue,” where people may find it difficult to stay on high-risk alert after weeks of social distancing and isolation to stop the spread of COVID-19.
Disrupting the brain’s orbitofrontal cortex with a noninvasive stimulation technique impairs a person’s ability to make inference-based decisions and may help treat psychiatric disorders, according to a recent Northwestern Medicine study.
John Csernansky, MD, the chair and Lizzie Gilman Professor of Psychiatry and Behavioral Sciences, has announced that he will be stepping down as chair after a distinguished tenure leading the department through unprecedented growth and expansion.
Joel Voss, PhD, and John Disterhoft, PhD, have received a $6.3 million grant from the NIH as part of the BRAIN Initiative.